Consistent with its known mechanism of action, orlistat administration improved insulin resistance but did not significantly alter GREM1 expression or circulating levels, suggesting that its metabolic effects are largely independent of the GREM1–BMP4 axis. Here, BMP4 is linked to Insulin resistance.